Literature DB >> 21880655

Detection of very early stent healing after primary angioplasty: an optical coherence tomographic observational study of chromium cobaltum and first-generation drug-eluting stents. The DETECTIVE study.

Francesco Prati1, Filippo Stazi, Jaime Dutary, Alessio La Manna, Alessandro Di Giorgio, Tomasz Pawlosky, Nieves Gonzalo, Maria Elena Di Salvo, Fabrizio Imola, Corrado Tamburino, Mario Albertucci, Fernando Alfonso.   

Abstract

BACKGROUND: Lack of stent coverage appears to be associated with stent thrombosis, a problem of particular concern in patients with ST elevation myocardial infarction (STEMI).
METHODS: The DETECTIVE European Multicenter Registry was set up to address the early modality of stent healing in the setting of STEMI. The Registry compared, with an early optical coherence tomography (OCT) evaluation performed at 3-7 days, the patterns of coverage and apposition of the first generation of drug-eluting stents (DESs) and cobalt chromium non-drug-eluting stents (CCSs) that were deployed in culprit lesions and in non-culprit segments. The Registry included only patients with a multi-vessel disease to allow, at 3-7 days from the first angioplasty, a deferred OCT examination and a staged intervention in another vessel.
RESULTS: 28 stented lesions (15 patients) eventually entered the final OCT assessment. 13 stents were first-generation DESs, while the remaining 15 were CCSs. 18 stents (64%) were deployed at culprit STEMI lesions, and the remaining 10 (36%) were deployed at non-culprit sites. The distribution of clinical and procedural variables in DES and CCS as well as in culprit and non-culprit sites was not different. In total, 27,019 struts were analysed in 28 stents. The percentage of stent uncoverage in the overall analysis was 11.7%, while the percentage of malapposition and that of struts covered with thrombus were 4.8% and 2.2%, respectively. A low percentage of strut uncoverage was found in all the four studied subgroups: DES 12.8%, CCS 10.9%, stents deployed in culprit lesions 13.2% and stents deployed in non-culprit lesions 8.7%.
CONCLUSIONS: In conclusion, our data show that in patients with STEMI, a very high percentage of stent struts is covered by an early thin rim of tissue within 7 days after stent positioning. The present data bring new insights in the mechanism and timing of strut coverage.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21880655     DOI: 10.1136/heartjnl-2011-300782

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  5 in total

1.  Utility of optical coherence tomography to assess a hazy intracoronary image after percutaneous coronary intervention.

Authors:  Sebastian Carrizo; Pablo Salinas; Santiago Jimenez-Valero; Raul Moreno
Journal:  Korean Circ J       Date:  2013-01-31       Impact factor: 3.243

2.  Expert review document part 2: methodology, terminology and clinical applications of optical coherence tomography for the assessment of interventional procedures.

Authors:  Francesco Prati; Giulio Guagliumi; Gary S Mintz; Marco Costa; Evelyn Regar; Takashi Akasaka; Peter Barlis; Guillermo J Tearney; Ik-Kyung Jang; Elosia Arbustini; Hiram G Bezerra; Yukio Ozaki; Nico Bruining; Darius Dudek; Maria Radu; Andrejs Erglis; Pascale Motreff; Fernando Alfonso; Kostas Toutouzas; Nieves Gonzalo; Corrado Tamburino; Tom Adriaenssens; Fausto Pinto; Patrick W J Serruys; Carlo Di Mario
Journal:  Eur Heart J       Date:  2012-05-31       Impact factor: 29.983

3.  The avantgarde carbostent in patients scheduled for undelayable noncardiac surgery.

Authors:  Carlo Briguori; Gabriella Visconti; Francesca De Micco; Amelia Focaccio
Journal:  Thrombosis       Date:  2012-02-19

4.  Optical Coherence Tomography Imaging: Novel Insights into the Vascular Response After Coronary Stent Implantation.

Authors:  Milosz Jaguszewski; Ulf Landmesser
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-05-05

5.  Optical Coherence Tomography: Potential Clinical Applications.

Authors:  Antonios Karanasos; Jurgen Ligthart; Karen Witberg; Gijs van Soest; Nico Bruining; Evelyn Regar
Journal:  Curr Cardiovasc Imaging Rep       Date:  2012-05-03
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.